e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
New treatments and old dilemmas in the clinical management of lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of atrial fibrillation in patients with sarcoidosis
V. Kouranos, A. Rapti, E. Manali, K. Aggeli, L. Velentza, E. Peros, T. Papaioannou, A. Kalianos, G. Kaltsakas, K. Vlachos, C. Kostopoulos, S. Papiris, N. Koulouris, E. Gialafos (Athens, Greece)
Source:
Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Session:
New treatments and old dilemmas in the clinical management of lung diseases
Session type:
Poster Discussion
Number:
3365
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Kouranos, A. Rapti, E. Manali, K. Aggeli, L. Velentza, E. Peros, T. Papaioannou, A. Kalianos, G. Kaltsakas, K. Vlachos, C. Kostopoulos, S. Papiris, N. Koulouris, E. Gialafos (Athens, Greece). Prevalence of atrial fibrillation in patients with sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3365
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Evaluation of ventricular arrhythmogenesis in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD)
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Cardiac remodeling and left ventricular-arterial coupling in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Risk factors for asymptomatic atrial fibrillation in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Atrial fibrillation and stroke risk in relation to COPD and chronic productive cough
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Exacerbations of bronchiectasis: Etiology and outcome
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept